Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling

Tee, Andrew R., Fingar, Diane C., Manning, Brendan D., Kwiatkowski, David J., Cantley, Lewis C., Blenis, John·2002·Proceedings of the National Academy of Sciences
DOI 10.1073/pnas.202476899

Cited by (828)

Items 101–200 of 828

  1. Hydrogen peroxide inhibits mTOR signaling by activation of AMPKα leading to apoptosis of neuronal cells
    Chen, Long, Xu, Baoshan, Liu, Lei, Luo, Yan, Yin, Jun, Zhou, Hongyu, Chen, Wenxing, Shen, Tao, Han, Xiuzhen, Huang, Shile · 2010 · Laboratory Investigation
  2. TSC1 Stabilizes TSC2 by Inhibiting the Interaction between TSC2 and the HERC1 Ubiquitin Ligase
    Chong-Kopera, Huira, Inoki, Ken, Li, Yong, Zhu, Tianqing, Garcia-Gonzalo, Francesc R., Rosa, Jose Luis, Guan, Kun-Liang · 2006 · Journal of Biological Chemistry
  3. Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of Tuberous Sclerosis Complex
    L.-H. Zeng, Nicholas R. Rensing, B. Zhang, David H. Gutmann, Michael J. Gambello, Michael Wong · 2010 · Human Molecular Genetics
  4. Staying alive
    James R. Valcourt, Johanna M. S. Lemons, Erin M. Haley, Mina L. Kojima, Olukunle O. Demuren, Hilary A. Coller · 2012 · Cell Cycle
  5. mTOR Ser-2481 Autophosphorylation Monitors mTORC-specific Catalytic Activity and Clarifies Rapamycin Mechanism of Action
    Ghada A. Soliman, Hugo A. Acosta-Jaquez, Elaine A. Dunlop, Bilgen Ekim Üstünel, Nicole E. Maj, Andrew R. Tee, Diane C. Fingar · 2009 · Journal of Biological Chemistry
  6. Protein interactome reveals converging molecular pathways among autism disorders
    Sakai, Yasunari, Shaw, Chad A., Dawson, Brian C., Dugas, Diana V., Al-Mohtaseb, Zaina, Hill, David E., Zoghbi, Huda Y. · 2011 · Science Translational Medicine
  7. Metabolic transformation in cancer
    Daniel A. Tennant, Raúl V. Durán, Houda Boulahbel, Eyal Gottlieb · 2009 · Carcinogenesis
  8. Regulation of protein synthesis associated with skeletal muscle hypertrophy by insulin-, amino acid- and exercise-induced signalling
    Douglas R. Bolster, Leonard S. Jefferson, Scot R. Kimball · 2004 · Proceedings of The Nutrition Society
  9. Multiple amino acid sensing inputs to mTORC1
    Mitsugu Shimobayashi, Michael N. Hall · 2015 · Cell Research
  10. Inactivation of the Tuberous Sclerosis Complex-1 and -2 Gene Products Occurs by Phosphoinositide 3-Kinase/Akt-dependent and -independent Phosphorylation of Tuberin
    Andrew R. Tee, Rana Anjum, John Blenis · 2003 · Journal of Biological Chemistry
  11. Mammalian Target of Rapamycin (mTOR) Activation Increases Axonal Growth Capacity of Injured Peripheral Nerves
    Namiko Abe, Steven Borson, Michael J. Gambello, Fan Wang, Valeria Cavalli · 2010 · Journal of Biological Chemistry
  12. Sustained Activation of the JNK Cascade and Rapamycin-Induced Apoptosis Are Suppressed by p53/p21Cip1
    Shile Huang, Lili Shu, Michael B. Dilling, John B. Easton, Franklin C. Harwood, Hidenori Ichijo, Peter J. Houghton · 2003 · Molecular Cell
  13. Loss of Tsc1 In Vivo Impairs Hippocampal mGluR-LTD and Increases Excitatory Synaptic Function
    Bateup, H. S., Takasaki, K. T., Saulnier, J. L., Denefrio, C. L., Sabatini, B. L. · 2011 · Journal of Neuroscience
  14. Chapter 1 Physiological Roles of Ribosomal Protein S6: One of Its Kind
    Oded Meyuhas · 2008 · International review of cytology
  15. Metabolic Reprogramming by the PI3K-Akt-mTOR Pathway in Cancer
    Evan C. Lien, Costas Andreas Lyssiotis, Lewis C. Cantley · 2016 · Recent results in cancer research/Recent Results in Cancer Research
  16. Quantitative phosphorylation profiling of the ERK/p90 ribosomal S6 kinase-signaling cassette and its targets, the tuberous sclerosis tumor suppressors
    Bryan A. Ballif, Philippe P. Roux, Scott A. Gerber, Jeffrey P. MacKeigan, John Blenis, Steven P. Gygi · 2005 · Proceedings of the National Academy of Sciences
  17. Comprehensive Proteomic Analysis of Interphase and Mitotic 14-3-3-binding Proteins
    Sarah E. M. Meek, William S. Lane, Helen M. Piwnica-Worms · 2004 · Journal of Biological Chemistry
  18. Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease
    Aristotelis Astrinidis, Elizabeth P. Henske · 2005 · Oncogene
  19. Mammalian target of rapamycin inhibition as therapy for hematologic malignancies
    Amit W. Panwalkar, Srđan Verstovšek, Francis Joseph Giles · 2004 · Cancer
  20. Genetically engineered human cortical spheroid models of tuberous sclerosis
    John D. Blair, Dirk F. Hockemeyer, Helen S. Bateup · 2018 · Nature Medicine
  21. Distinct Signaling Events Downstream of mTOR Cooperate To Mediate the Effects of Amino Acids and Insulin on Initiation Factor 4E-Binding Proteins
    Xuemin Wang, Anne Beugnet, Mirei Murakami, Shinya Yamanaka, Christopher G. Proud · 2005 · Molecular and Cellular Biology
  22. Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: from tuberous sclerosis to common acquired epilepsies.
    Wong, Michael · 2010 · Epilepsia
  23. Curcumin Disrupts the Mammalian Target of Rapamycin-Raptor Complex
    Christopher S. Beevers, Long Chen, Lei Liu, Yan Luo, Nicholas J. G. Webster, Shile Huang · 2009 · Cancer Research
  24. Changes in Lung Function and Chylous Effusions in Patients With Lymphangioleiomyomatosis Treated With Sirolimus
    Angelo M. Taveira‐DaSilva, Olanda M. Hathaway, Mario P. Stylianou, Joel Moss · 2011 · Annals of Internal Medicine
  25. Human Cytomegalovirus Protein UL38 Inhibits Host Cell Stress Responses by Antagonizing the Tuberous Sclerosis Protein Complex
    Moorman, Nathaniel J., Cristea, Ileana M., Terhune, Scott S., Rout, Michael P., Chait, Brian T., Shenk, Thomas · 2008 · Cell Host & Microbe
  26. Class I A Phosphoinositide 3-Kinase Regulates Heart Size and Physiological Cardiac Hypertrophy
    Ji Luo, Julie R. McMullen, Cassandra L. Sobkiw, Li Zhang, Adam L. Dorfman, Megan C. Sherwood, M. Nicole Logsdon, James W. Horner, Ronald Anthony DePinho, Seigo Izumo et al. · 2005 · Molecular and Cellular Biology
  27. Defining the underlying defect in insulin action in type 2 diabetes
    Thiago M. Batista, Nida Haider, C. Ronald Kahn · 2021 · Diabetologia
  28. Inorganic polyphosphate stimulates mammalian TOR, a kinase involved in the proliferation of mammary cancer cells
    Lihong Wang, Cresson D. Fraley, Jesika S. Faridi, Arthur Kornberg, Richard A. Roth · 2003 · Proceedings of the National Academy of Sciences
  29. LARP1 functions as a molecular switch for mTORC1-mediated translation of an essential class of mRNAs
    Sungki Hong, Mallory Freeberg, Ting Han, Avani Kamath, Yao Yao, Tomoko Fukuda, Tsukasa Suzuki, John K. Kim, Ken Inoki · 2017 · eLife
  30. Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy
    Christopher G. Proud · 2004 · Cardiovascular Research
  31. mTOR signaling in stem and progenitor cells
    Delong Meng, Anderson R. Frank, Jenna L. Jewell · 2018 · Development
  32. Regulation of mTOR Complex 1 (mTORC1) by Raptor Ser863 and Multisite Phosphorylation
    Kathryn G. Foster, Hugo A. Acosta-Jaquez, Yves Roméo, Bilgen Ekim Üstünel, Ghada A. Soliman, Audrey Carriere, Philippe P. Roux, Bryan A. Ballif, Diane C. Fingar · 2009 · Journal of Biological Chemistry
  33. Integration of Growth Factor and Nutrient Signaling
    Alykhan F. Shamji, Paul Nghiem, Stuart L. Schreiber · 2003 · Molecular Cell
  34. The mTOR pathway and its role in human genetic diseases
    M ROSNER, Michaela Hanneder, Nicol Siegel, Alessandro Valli, Christiane Fuchs, M HENGSTSCHLAGER · 2008 · Mutation Research/Reviews in Mutation Research
  35. Training for Endurance and Strength
    Keith Baar · 2006 · Medicine & Science in Sports & Exercise
  36. Behavioral phenotypes of genetic mouse models of autism
    Tatiana M. Kazdoba, Prescott T. Leach, Jacqueline N. Crawley · 2015 · Genes Brain & Behavior
  37. Phospholipase D1 is an effector of Rheb in the mTOR pathway
    Yu Sun, Yimin Fang, Mee‐Sup Yoon, Conghao Zhang, Marta Roccio, Fried J. T. Zwartkruis, Michelle D. Armstrong, H. Alex Brown, Jie Chen · 2008 · Proceedings of the National Academy of Sciences
  38. Regulation of Body Size and Growth Control
    Michael James Texada, Takashi Koyama, Kim Rewitz · 2020 · Genetics
  39. mTORC1 and Nutrient Homeostasis: The Central Role of the Lysosome
    Yoana Rabanal‐Ruiz, Viktor I. Korolchuk · 2018 · International Journal of Molecular Sciences
  40. Leucine stimulates protein synthesis in skeletal muscle of neonatal pigs by enhancing mTORC1 activation
    Agus Suryawan, Asumthia S. Jeyapalan, Renán A. Orellana, Fiona A. Wilson, Hanh V. Nguyen, Teresa A. Davis · 2008 · American Journal of Physiology-Endocrinology and Metabolism
  41. Airway Smooth Muscle Growth in Asthma: Proliferation, Hypertrophy, and Migration
    John Kelley Bentley, Marc B. Hershenson · 2007 · Proceedings of the American Thoracic Society
  42. Signaling control of mRNA translation in cancer pathogenesis
    Eric C. Holland, Nahum Sonenberg, Pier Paolo Pandolfi, George Thomas · 2004 · Oncogene
  43. Tuberous Sclerosis Complex
    Francis J. DiMario, Mustafa Şahin, Darius Ebrahimi‐Fakhari · 2015 · Pediatric Clinics of North America
  44. Mammalian Target of Rapamycin (mTOR) Pathways in Neurological Diseases
    Michael Wong · 2013 · Biomedical Journal
  45. Site-Specific mTOR Phosphorylation Promotes mTORC1-Mediated Signaling and Cell Growth
    Hugo A. Acosta-Jaquez, Jennifer A. Keller, Kathryn G. Foster, Bilgen Ekim Üstünel, Ghada A. Soliman, Edward P. Feener, Bryan A. Ballif, Diane C. Fingar · 2009 · Molecular and Cellular Biology
  46. mTOR signaling in tumorigenesis
    Kai Lin Xu, Pengda Liu, Wenyi Wei · 2014 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  47. Role of mTOR Signaling in Female Reproduction
    Zaixin Guo, Qi Yu · 2019 · Frontiers in Endocrinology
  48. Akt activation disrupts mammary acinar architecture and enhances proliferation in an mTOR-dependent manner
    Jayanta Debnath, Stephanie J. Walker, Joan S. Brugge · 2003 · The Journal of Cell Biology
  49. The p38 and MK2 Kinase Cascade Phosphorylates Tuberin, the Tuberous Sclerosis 2 Gene Product, and Enhances Its Interaction with 14-3-3
    Yong Li, Ken Inoki, Panayiotis O. Vacratsis, Kun‐Liang Guan · 2003 · Journal of Biological Chemistry
  50. AMP-activated protein kinase can induce apoptosis of insulin-producing MIN6 cells through stimulation of c-Jun-N-terminal kinase
    Benjamin Ate Kefas, Ying Cai, Z. Ling, Harry Heimberg, L. Hue, DANIEL G. PIPELEERS, Mark Van de Casteele · 2003 · Journal of Molecular Endocrinology
  51. Genetic Variations in the PI3K/PTEN/AKT/mTOR Pathway Are Associated With Clinical Outcomes in Esophageal Cancer Patients Treated With Chemoradiotherapy
    Michelle A.T. Hildebrandt, Hushan Yang, Mien‐Chie Hung, Julie G. Izzo, Maosheng Huang, Jie Ming Lin, Jaffer A. Ajani, Xifeng Wu · 2009 · Journal of Clinical Oncology
  52. Loss of Tsc1 or Tsc2 induces vascular endothelial growth factor production through mammalian target of rapamycin.
    Nisreen El-Hashemite, Victoria Walker, Hongbing Zhang, David J. Kwiatkowski · 2003 · PubMed
  53. Tuberous sclerosis complex: from Drosophila to human disease
    Duojia Pan, Jixin Dong, Yong Zhang, Xinsheng Gao · 2004 · Trends in Cell Biology
  54. The role of autophagy in hepatocellular carcinoma: friend or foe
    Lian Liu, Jiazhi Liao, Xingxing He, Peiyuan Li · 2017 · Oncotarget
  55. Targeting the molecular target of rapamycin (mTOR)
    Eric Keith Rowinsky · 2004 · Current Opinion in Oncology
  56. Cyclin D1 and c-myc Internal Ribosome Entry Site (IRES)-dependent Translation Is Regulated by AKT Activity and Enhanced by Rapamycin through a p38 MAPK- and ERK-dependent Pathway
    Yijiang Shi, Anushree Sharma, Hong Wu, Alan K. Lichtenstein, Joseph Gera · 2005 · Journal of Biological Chemistry
  57. Biallelic TSC gene inactivation in tuberous sclerosis complex
    Crino, Peter B., Aronica, Eleonora, Baltuch, Gordon, Nathanson, Katherine L. · 2010 · Neurology
  58. Genetic Causes of Brain Tumors: Neurofibromatosis, Tuberous Sclerosis, von Hippel-Lindau, and Other Syndromes
    Christopher James Farrell, Scott Randall Plotkin · 2007 · Neurologic Clinics
  59. Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 2: PI3K/Akt/PTEN, mTOR, SHH/PTCH and angiogenesis
    Herbert B. Newton · 2004 · Expert Review of Anticancer Therapy
  60. The Complexes of Mammalian Target of Rapamycin
    Hongyu Zhou, Shile Huang · 2010 · Current Protein and Peptide Science
  61. The tuberous sclerosis gene products hamartin and tuberin are multifunctional proteins with a wide spectrum of interacting partners
    Margit Rosner, Michaela Hanneder, Nicol Siegel, Alessandro Valli, Markus Hengstschläger · 2008 · Mutation Research/Reviews in Mutation Research
  62. Tuberous sclerosis complex: genetics to pathogenesis
    Vinodh Narayanan · 2003 · Pediatric Neurology
  63. Dietary intervention in acne
    Bodo Clemens Melnik · 2012 · Dermato-Endocrinology
  64. Leucine signaling in the pathogenesis of type 2 diabetes and obesity
    Bodo Clemens Melnik · 2012 · World Journal of Diabetes
  65. The tumor suppressor FLCN mediates an alternate mTOR pathway to regulate browning of adipose tissue
    Shogo Wada, Michael D. Neinast, Cholsoon Jang, Yasir H. Ibrahim, Gina Lee, Apoorva Babu, Jian Li, Atsushi Hoshino, Glenn C. Rowe, James Rhee et al. · 2016 · Genes & Development
  66. mTOR signaling for biological control and cancer
    Anya Alayev, Marina K. Holz · 2013 · Journal of Cellular Physiology
  67. Regulation of mTOR by amino acids and resistance exercise in skeletal muscle
    Louise Deldicque, Daniel Theisen, Marc Francaux · 2005 · European Journal of Applied Physiology
  68. Inhibition of Autophagosome Formation by the Benzoporphyrin Derivative Verteporfin
    Elizabeth Donohue, Andrew Norman Tovey, A. Wayne Vogl, Steve Arns, Ethan D. Sternberg, Robert Norman Young, Michel Roberge · 2010 · Journal of Biological Chemistry
  69. Yes-associated protein (YAP) in pancreatic cancer: at the epicenter of a targetable signaling network associated with patient survival
    Enrique Rozengurt, James W. Sinnett‐Smith, Guido Eibl · 2018 · Signal Transduction and Targeted Therapy
  70. Regulation of the small GTPase Rheb by amino acids
    Marta Roccio, Johannes L. Bos, Fried J. T. Zwartkruis · 2005 · Oncogene
  71. Causes of mortality in individuals with tuberous sclerosis complex
    Sam Amin, Andrew L. Lux, Nuala Calder, Matthew J. Laugharne, John P Osborne, Finbar J. O'Callaghan · 2016 · Developmental Medicine & Child Neurology
  72. Genome-wide CRISPR screens reveal multitiered mechanisms through which mTORC1 senses mitochondrial dysfunction
    Condon, Kendall J., Orozco, Jose M., Adelmann, Charles H., Spinelli, Jessica B., van der Helm, Pim W., Roberts, Justin M., Kunchok, Tenzin, Sabatini, David M. · 2021 · Proceedings of the National Academy of Sciences
  73. PI3-kinase and TOR: PIKTORing cell growth
    Celeste J. Richardson, Stefanie S. Schalm, John Blenis · 2004 · Seminars in Cell and Developmental Biology
  74. Genotype and psychological phenotype in tuberous sclerosis
    J C Lewis, H V Thomas, K C Murphy, J R Sampson · 2004 · Journal of Medical Genetics
  75. Epileptogenesis and Reduced Inward Rectifier Potassium Current in Tuberous Sclerosis Complex‐1–Deficient Astrocytes
    Laura A. Jansen, Erik J. Uhlmann, Peter B. Crino, David H. Gutmann, Michael Wong · 2005 · Epilepsia
  76. When Overgrowth Bumps Into Cancer: The PTEN-Opathies
    Jessica L. Mester, Charis Eng · 2013 · American Journal of Medical Genetics Part C Seminars in Medical Genetics
  77. The mammalian target of rapamycin-signaling pathway in regulating metabolism and growth1,2
    X. Yang, C.B. Yang, A. Farberman, Todd Christopher Rideout, C. F. M. de Lange, J. France, Ming Z. Fan · 2007 · Journal of Animal Science
  78. Fission yeast Tor2 links nitrogen signals to cell proliferation and acts downstream of the Rheb GTPase
    Masahiro Uritani, Hidetoshi Hidaka, Yukari Hotta, Masaru Ueno, Takashi Ushimaru, Takashi Toda · 2006 · Genes to Cells
  79. The Multifaceted Role of Nutrient Sensing and mTORC1 Signaling in Physiology and Aging
    Stephanie Fernandes, Constantinos Demetriades · 2021 · Frontiers in Aging
  80. Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): Clinical recommendations
    Sergiusz Jóźwiak, Rima Nabbout, Paolo Curatolo · 2013 · European Journal of Paediatric Neurology
  81. Mechanisms of Kaempferol in the treatment of diabetes: A comprehensive and latest review
    Yan Yang, Zhengtao Chen, Xiaoyan Zhao, Hongyan Xie, Lian Du, Hong Li Gao, Chunguang Xie · 2022 · Frontiers in Endocrinology
  82. mTOR Kinase Domain Phosphorylation Promotes mTORC1 Signaling, Cell Growth, and Cell Cycle Progression
    Bilgen Ekim Üstünel, Brian Magnuson, Hugo A. Acosta-Jaquez, Jennifer A. Keller, Edward P. Feener, Diane C. Fingar · 2011 · Molecular and Cellular Biology
  83. Granulocyte-Macrophage Colony-Stimulating Factor Is a Chemoattractant Cytokine for Human Neutrophils: Involvement of the Ribosomal p70 S6 Kinase Signaling Pathway
    Julián Gómez-Cambronero, Jeffrey M. Horn, Cassandra C. Paul, Michael A Baumann · 2003 · The Journal of Immunology
  84. Lymphangioleiomyomatosis
    Angelo M. Taveira‐DaSilva, Wendy K. Steagall, Joel Moss · 2006 · Cancer Control
  85. Rapamycin-Resistant mTORC1 Kinase Activity Is Required for Herpesvirus Replication
    Nathaniel J. Moorman, Thomas E. Shenk · 2010 · Journal of Virology
  86. Stress-mediated translational control in cancer cells
    Gabriel Leprivier, Barak Rotblat, Debjit Khan, Eric Jan, Poul H. B. Sorensen · 2014 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
  87. Mammalian target of rapamycin inhibition as a therapeutic strategy in the management of urologic malignancies
    Jorge Alberto Garcia, David Danielpour · 2008 · Molecular Cancer Therapeutics
  88. Resistance exercise initiates mechanistic target of rapamycin (mTOR) translocation and protein complex co-localisation in human skeletal muscle
    Zhe Song, Daniel R. Moore, Nathan W. Hodson, Carl Ward, Jessica R. Dent, Mary F. O’Leary, Andrew M. Shaw, David Lee Hamilton, Sovan Sarkar, Yann‐Gaël Gangloff et al. · 2017 · Scientific Reports
  89. Involvement of Insulin Receptor Substrate 2 in Mammary Tumor Metastasis
    Julie A. Nagle, Zhefu Ma, Maura A. Byrne, Morris F. White, Leslie M. Shaw · 2004 · Molecular and Cellular Biology
  90. Are neuroendocrine tumours a feature of tuberous sclerosis? A systematic review
    Dorota Dworakowska B, Ashley Barry Grossman · 2008 · Endocrine Related Cancer
  91. Genetics and Molecular Biology of Tuberous Sclerosis Complex
    Valerio Napolioni, Paolo Curatolo · 2008 · Current Genomics
  92. Emerging Role of mTOR in the Response to Cancer Therapeutics
    Erika Ilagan, Brendan D. Manning · 2016 · Trends in cancer
  93. Current development of the second generation of mTOR inhibitors as anticancer agents
    Hongyu Zhou, Shile Huang · 2011 · 癌症：英文版
  94. AMPKα1 deficiency amplifies proinflammatory myeloid APC activity and CD40 signaling
    Kelly Casey Carroll, Benoı̂t Viollet, Jill Suttles · 2013 · Journal of Leukocyte Biology
  95. mTOR Signaling in Parkinson’s Disease
    Aiping Lan, Jun Chen, Yuliang Zhao, Zhifang Chai, Yi Hu · 2016 · NeuroMolecular Medicine
  96. Human Papillomavirus 16 E6 Oncoprotein Interferences with Insulin Signaling Pathway by Binding to Tuberin
    Zheming Lu, Xiuhua Hu, Yong Li, Li Zheng, Yue Zhou, Haidi Jiang, Tao Ning, Zhuoma Basang, Chunfeng Zhang, Yang Ke · 2004 · Journal of Biological Chemistry
  97. Tumorigenic activity and therapeutic inhibition of Rheb GTPase
    Konstantinos J. Mavrakis, Hong Zhu, Ricardo L.A. Silva, John R. Mills, Julie Teruya‐Feldstein, Scott W. Lowe, Wayne Tam, Jerry Pelletier, Hans‐Guido Wendel · 2008 · Genes & Development
  98. Mammalian Target of Rapamycin Inhibition
    Janice P. Dutcher · 2004 · Clinical Cancer Research
  99. Analysis of mTOR signaling by the small G‐proteins, Rheb and RhebL1
    Andrew R. Tee, John Blenis, Christopher G. Proud · 2005 · FEBS Letters
  100. Dopaminergic Dysregulation in Syndromic Autism Spectrum Disorders: Insights From Genetic Mouse Models
    Polina Kosillo, Helen S. Bateup · 2021 · Frontiers in Neural Circuits